
Pliant Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis. Its lead product candidate, PLN-74809, is an oral small-molecule dual that helps in the treatment of idiopathic pulmonary fibrosis. Pliant Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis. Its lead product candidate, PLN-74809, is an oral small-molecule dual that helps in the treatment of idiopathic pulmonary fibrosis.
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.17 | -10.2409638554 | 1.66 | 1.7 | 1.47 | 2168306 | 1.56462018 | CS |
4 | -1.7 | -53.2915360502 | 3.19 | 3.46 | 1.26 | 3605723 | 1.71046488 | CS |
12 | -11.82 | -88.8054094666 | 13.31 | 13.71 | 1.26 | 2733640 | 3.21206482 | CS |
26 | -10.01 | -87.0434782609 | 11.5 | 16.1 | 1.26 | 1502937 | 5.07056143 | CS |
52 | -13.04 | -89.7453544391 | 14.53 | 16.52 | 1.26 | 979239 | 6.93809329 | CS |
156 | -6.01 | -80.1333333333 | 7.5 | 36.64 | 1.26 | 829658 | 15.4082662 | CS |
260 | -21.01 | -93.3777777778 | 22.5 | 43.92 | 1.26 | 562966 | 16.15394357 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約